Bladder cancer
Conditions
Interventions
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
Male
Age
25 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1 In line with transurethral resection of bladder tumor (TURPBT), and pathological diagnosis of malignant tumors; 2 The Karnofsky Performance Status (KPS) score is >60 points, and the expected survival period is >1 year; 3 Aged 25 to 80 years; 4 Syndrome differentiation belongs to the syndrome type of "qi and blood deficiency and phlegm poisoning internal knot" in traditional Chinese medicine; 5 Those who have voluntarily signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1 Allergic constitution and those who are allergic to experimental drugs; 2 Patients with renal cancer, bladder tuberculosis, and urinary calculi; 3 Combined with other malignant tumor patients; 4 Patients with blood system diseases, coagulopathy and autoimmune diseases; 5 Combined with severe cardiovascular disease, cerebrovascular disease, hematopoietic system disease, neuropathic patients; 6 Participated in other clinical researchers 3 months before the trial; For the above 6 exclusion criteria, as long as one of the criteria is met, the exclusion criteria are met and need to be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bladder cancer syndrome score;Tumor patient Karnofsky Performance Status; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome score; | — |
Countries
China
Contacts
Public ContactYaosheng Zhang
Department of Urology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Outcome results
None listed